1,2-Dichloroethane → HCID 66970642, 화합물

HRID 1361518

반응식

HRID 1361518 반응식
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([O:16][CH3:17])=[C:6]([C:8]2([O:14][CH3:15])[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[CH:7]=1.[BH-](O[C:28]([CH3:30])=O)(OC(C)=O)OC(C)=O.[Na+].Cl[CH2:33][CH2:34]Cl>>[C@H:34]12[CH2:33][C@H:7]([CH:2]=[CH:3]1)[CH2:6][C@@H:28]2[CH2:30][N:11]1[CH2:10][CH2:9][C:8]([C:6]2[CH:7]=[C:2]([Cl:1])[CH:3]=[CH:4][C:5]=2[O:16][CH3:17])([O:14][CH3:15])[CH2:13][CH2:12]1

참가 물질

4

반응물 3

HCID 111,2-DichloroethaneHCID 5049666Sodium triacetoxyborohydrideHCID 587722974-(5-Chloro-2-methoxyphenyl)-4-methoxypiperidine

생성물 1

HCID 66970642HCID 66970642, 화합물

실험 절차

4-(5-Chloro-2-methoxyphenyl)-4-methoxypiperidine 5d (51 mg, 0.2 mmol) was dissolved in 1,2-dichloroethane (1.5 mL) and treated with (S,S,S)-norbornene carboxaldehyde (24 mg, 0.2 mmol, 1.0 eq), followed by the addition of NaBH(OAc)3 (65 mg, 0.3 mmol, 1.5 eq). The reaction was allowed to stir at room temperature for 1 h, quenched with methanol (1 mL) and allowed to stir for another 30 min (until gas evolution stopped). The crude reaction mixture was purified by HPLC (10-99 CH3CN gradient, 0.05% TFA) to provide the desired product 1-(((1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl)methyl)-4-(5-chloro-2-methoxyphenyl)-4-methoxypiperidine (compound no. 140) as the TFA salt. LC/MS (RP-C18, 10-99% CH3CN/0.05% TFA gradient over 5 min) m/z 362.2 [M+H]+, retention time 2.53 min.

후처리

  1. customquenched with methanol (1 mL)
  2. stirringto stir for another 30 min (until gas evolution stopped)
  3. customThe crude reaction mixture
  4. customwas purified by HPLC (10-99 CH3CN gradient, 0.05% TFA)

출처 및 근거

ORD 기록
ord-1aa2781b4e1941ba860470fe5eea490a
출처 데이터셋
uspto-grants-2011_02
특허 번호
US07880007B2

연결된 노트

불러오는 중…